Rhythm Pharmaceuticals Statistics
NASDAQ: RYTMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
112.36-4.44 (-3.80%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Rhythm Pharmaceuticals by the numbers
Rhythm Pharmaceuticals has a market capitalization of $7.79 billion based on 69.33M shares outstanding. With trailing EPS of $-2.91, Rhythm Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.6% above its 50-day average and 15.3% above its 200-day average.
Average daily trading volume is 1.10M shares, or about $123.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RYTM valuation vs. peer median
| Metric | RYTM | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.79B | $7.46B | +4% |
| Avg. volume | 1.10M | 1.58M | -31% |
Peer median across 8 companies: PTGX, SMMT, ALKS, KNSA, AMRX, PRAX, CYTK, CORT.
Valuation
- Market cap
- $7.79B
- Price / sales (latest FY)
- 41.05
- EPS (TTM)
- $-2.91
- Shares outstanding
- 69.33M
Price and trading
- Previous close
- 116.80
- Open
- 115.46
- Day range
- 112.00 – 117.01
- 52-week range
- 74.50 – 122.20
- 52-week change
- +10.44%
- Beta
- —
- Volume
- 1.50M
- Average volume
- 1.10M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 7.79B
- Forward Pe
- -86.55
- Eps
- -2.91
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 122.20
- Week52 Low
- 74.50
- Avg Volume
- 1.10M
- Shares Outstanding
- 69.33M
- Ma50
- 98.08
- Ma200
- 97.45
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -8.05%
- Pct From52w Low
- 50.82%